Literature DB >> 23880636

Diffusion-weighted magnetic resonance imaging for predicting and detecting the early response to chemoradiotherapy of advanced esophageal squamous cell carcinoma.

Shunsuke Imanishi1, Kiyohiko Shuto, Tomoyoshi Aoyagi, Tsuguaki Kono, Hiroshige Saito, Hisahiro Matsubara.   

Abstract

BACKGROUND: The aim of this study was to investigate the utility of the apparent diffusion coefficient (ADC) value in diffusion-weighted magnetic resonance imaging (DWMRI) for prediction and early detection of treatment response in advanced esophageal squamous cell carcinoma.
METHOD: DWMRI was performed in 27 patients with primary cT4 esophageal carcinoma that were undergoing chemoradiotherapy before treatment and after 20 and 40 Gy. We calculated tumor ADCs and association of the treatment effect between responders and nonresponders.
RESULTS: The ADC at the time of 20 Gy was significantly higher in responders compared to nonresponders (1.13 vs. 0.93; p = 0.005). The ADC cut-off value was set at 1.00 × 10(-3) mm(2)/s and the ADC predicted the responders with a sensitivity, positive predictive value and accuracy of 79, 73 and 74%, respectively. The increased rate of the ADC at the time of 20 Gy (ΔADC20) was also significantly higher in responders compared to nonresponders (35.4 vs. 1.5%; p = 0.0007). An ADC cut-off value for ΔADC20 of 15% predicted the responders with a sensitivity, positive predictive value and accuracy of 71, 100 and 85%, respectively.
CONCLUSION: The ADC values predicted the prognosis of patients with advanced esophageal squamous cell carcinoma as well as the treatment response.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23880636     DOI: 10.1159/000351435

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  18 in total

Review 1.  Chemoradiotherapy and surgery for T4 esophageal cancer in Japan.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Surg Today       Date:  2015-01-13       Impact factor: 2.549

2.  Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.

Authors:  Na-Na Sun; Chang Liu; Xiao-Lin Ge; Jie Wang
Journal:  Diagn Interv Radiol       Date:  2018-07       Impact factor: 2.630

3.  Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?

Authors:  Francesco Giganti; Annalaura Salerno; Alessandro Ambrosi; Damiano Chiari; Elena Orsenigo; Antonio Esposito; Luca Albarello; Elena Mazza; Carlo Staudacher; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Radiol Med       Date:  2015-09-21       Impact factor: 3.469

4.  Clinical response assessment on DW-MRI compared with FDG-PET/CT after neoadjuvant chemoradiotherapy in patients with oesophageal cancer.

Authors:  Sophie E Vollenbrock; Francine E M Voncken; Doenja M J Lambregts; Monique Maas; Maarten L Donswijk; Erik Vegt; Leon C Ter Beek; Jolanda M van Dieren; Johanna W van Sandick; Berthe M P Aleman; Regina G H Beets-Tan; Annemarieke Bartels-Rutten
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-22       Impact factor: 9.236

5.  Radiomic analysis in T2W and SPAIR T2W MRI: predict treatment response to chemoradiotherapy in esophageal squamous cell carcinoma.

Authors:  Zhen Hou; Shuangshuang Li; Wei Ren; Juan Liu; Jing Yan; Suiren Wan
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

6.  Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.

Authors:  Jian He; Hua Shi; Zhuping Zhou; Jun Chen; Wenxian Guan; Hao Wang; Haiping Yu; Song Liu; Zhengyang Zhou; Xiaofeng Yang; Tian Liu
Journal:  BMC Cancer       Date:  2015-10-20       Impact factor: 4.430

Review 7.  Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review.

Authors:  Chang-Juan Tao; Gang Lin; Ya-Ping Xu; Wei-Min Mao
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

8.  Predictive Value of Early Response to Chemoradiotherapy in Advanced Esophageal Squamous Cell Carcinoma by Diffusion-Weighted MR Imaging.

Authors:  Wei Chen; Ya-Ting Wang; Lili Guo; Zhaohuan Zhu; Hai-Fei Zhou; Genji Bai
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

9.  Study of diffusion-weighted magnetic resonance imaging in the evaluation of the response to AAV2-VEGF-Trap neoadjuvant treatment in a triple-negative breast cancer animal model.

Authors:  Jianhua Li; Pengjin Zhu; Lei Wang; Li Yang; Liqun Zou; Fabao Gao
Journal:  Cancer Med       Date:  2019-03-21       Impact factor: 4.452

10.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in assessing lymph node metastasis of esophageal cancer compared with PET.

Authors:  Kiyohiko Shuto; Tsuguaki Kono; Toru Shiratori; Yasunori Akutsu; Masaya Uesato; Mikito Mori; Kazuo Narushima; Shunsuke Imanishi; Yoshihiro Nabeya; Noriyuki Yanagawa; Shinichi Okazumi; Keiji Koda; Hisahiro Matsubara
Journal:  Esophagus       Date:  2019-12-09       Impact factor: 4.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.